InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
3
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by ARCH Venture Partners X, LLC. Insider active across 4 companies, notably Verve Therapeutics, Inc.. Aggregated, 10 disclosures have been logged. Split: 3 buys · 0 sell. Total volume traded: €31.7m. Activity tracked since 15 February 2024. The latest transaction was filed on 27 October 2025 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to ARCH Venture Partners X, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
1,915,700 shares@ US$2.61100.0% of flowCommon StockSEC:0001012975-25-000679:0
Canonical exit: 25 Jan 2026 (T+90)
3,030,300 shares@ US$3.3032.0% of flowCommon StockSEC:0001062993-25-013460:0
Canonical exit: 30 Oct 2025 (T+90)
3,200,000 shares@ US$6.25100.0% of flowCommon StockSEC:0001062993-24-003738:0
Canonical exit: 15 May 2024 (T+90)
703,061 sharesCommon StockSEC:0001062993-23-022480:0
1,176,593 sharesCommon StockSEC:0001062993-23-022480:1
684,167 sharesCommon StockSEC:0000899243-23-019273:0
684,167 sharesCommon StockSEC:0000899243-23-019274:0
5,728,297 sharesCommon StockSEC:0001628280-22-027125:0
5,527,777 sharesCommon StockSEC:0000899243-21-029077:0
1,254,404 sharesCommon Stock, par value $0.001SEC:0000899243-21-025507:0
10 of 10 declarations
About ARCH Venture Partners X, LLC
ARCH Venture Partners X, LLC is a declarant linked to Neumora Therapeutics, Inc., Prime Medicine, Inc., Erasca, Inc. and Verve Therapeutics, Inc. The record shows 10 filings in total, with buy volume in the sampled recent filings from 2021-06-23 to 2025-10-29 of EUR 31687871 and no reported sells.
